Lanster Capsule 15mg (Lansoprazole)

Adult dose

This medicine should be taken before meals. For patients who have difficulty swallowing the medicine, open the capsule, mix the contents with a small amount (60 mL) of orange or tomato juice, and administer immediately. To ensure the full dose is taken, rinse the glass with twice or more the amount of juice and drink immediately. After opening the capsule, do not chew or crush the contents before taking them. Short-term treatment of active duodenal ulcer: Administer lansoprazole 15 mg orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcer Administer lansoprazole 30 mg with clarithromycin 250 ∼ 500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days if necessary. Administer lansoprazole 30 mg with amoxicillin 1,000 mg 3 times daily (every 8 hours) for 14 days. Maintenance treatment after treatment of duodenal ulcer: Administer lansoprazole 15 mg orally once daily. Comparative clinical trials did not exceed 12 months. Treatment of NSAID-induced gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. Comparative clinical trials did not exceed 8 weeks. Reduction of the risk of NSAID-induced gastric ulcer: Administer lansoprazole 15 mg orally once daily for 12 weeks. Comparative clinical trials did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease Administer lansoprazole 15 mg orally once daily for 8 weeks. Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. Maintenance treatment after treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome The lansoprazole dose for pathological hypersecretory conditions varies for each patient. Treatment in adults is usually initiated at 60 mg once daily. The dose should be adjusted according to the patient's needs and may be continued as long as it is clinically effective. Doses of 90 mg per dose up to twice daily have been administered. If the daily dose exceeds 120 mg, it should be given in divided doses. Because clearance of this medicine is reduced in elderly patients, dose adjustment is necessary. Do not exceed a daily dose of 30 mg. Because metabolism and excretion of this medicine may be delayed in patients with hepatic impairment, administer cautiously, including consideration of dose adjustment.

Child dose

Children and adolescents aged 12 ∼ 17 years: Short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease — 15 mg once daily for 8 weeks Children and adolescents aged 12 ∼ 17 years: Short-term treatment of erosive reflux esophagitis — 30 mg once daily for 8 weeks Children aged 1 ∼ 11 years, 30 kg or less: 15 mg once daily for 12 weeks Children aged 1 ∼ 11 years, over 30 kg: 30 mg once daily for 12 weeks

This medication should not be used in patients with specific allergic reactions or during pregnancy. Care should be taken when administering this medication to patients with impaired liver function, the elderly, breastfeeding women, and children. Severe allergic reactions, blood disorders, liver dysfunction, and serious skin reactions may occur during treatment, so if abnormal symptoms appear, stop use immediately and consult medical personnel. Long-term use may result in nutrient deficiencies such as vitamin B12 deficiency or hypomagnesemia, thus regular testing is necessary. This medication inhibits gastric acid secretion, which may increase the risk of bacterial infections in the gastrointestinal tract, so if gastrointestinal symptoms such as diarrhea persist, inform medical personnel. Drug interactions may occur when taken with other medications; therefore, it is essential to inform medical personnel if taking antibiotics, antivirals, anticoagulants, immunosuppressants, etc. For long-term use, only the minimal effective dose should be used for the appropriate duration, and if symptoms suggestive of malignancy such as gastric ulcers are present, specialist diagnosis is required. Dizziness, drowsiness, and visual disturbances may occur, so caution is necessary when driving or operating machinery. In case of overdose, visit a hospital immediately for appropriate treatment; this medication is not removed by hemodialysis. When storing, keep out of reach of children, do not transfer to other containers, and if in oral dosage form, it is advisable to avoid using automatic dispensers.

• Anaphylactic reaction
• generalized rash
• facial swelling
• dyspnea
• shock
• pancytopenia
• agranulocytosis
• hemolytic anemia
• granulocytopenia
• thrombocytopenia

This medication must be stored in a tightly sealed container to avoid exposure to air or moisture. It is preferable to maintain a storage temperature between 1°C and 30°C. Proper storage will help ensure the medication's efficacy.

Appearance

A hard capsule filled with white to light brown granules

Package unit

30 capsules/bottle